FDA warns of brain problem with Glaxo seizure drug

Aug 12, 2010

(AP) -- Federal health regulators are warning doctors and patients that a seizure drug from GlaxoSmithKline can cause rare inflammation of the brain and spinal cord.

The Food and Administration says it is working with the British drugmaker Glaxo to add new warnings and labeling information to the company's drug Lamictal.

The agency said it has received reports of 40 cases of aseptic meningitis since Lamictal's approval in 1994 and last November. Thirty-five patients needed to be hospitalized, the agency said in a statement.

Aseptic meningitis is a dangerous inflammation of the brain and that can cause headache, fever, chills and vomiting. The problem can be caused by viruses, toxins and certain medications.

Explore further: Bangladesh jails three over drug scam that killed hundreds of children (Update)

not rated yet
add to favorites email to friend print save as pdf

Related Stories

FDA expands meningitis vaccine approval

Oct 22, 2007

The U.S. Food and Drug Administration has expanded approval for the use of Menactra, a bacterial meningitis vaccine, to children ages 2 to 10.

12 cases of brain disease after vaccines

Oct 24, 2006

The U.S. Food and Drug Administration said 12 cases of a neurological disorder have been reported following the application of a meningococcal vaccine.

Anti-cancer drug damages brain vessels

Feb 11, 2008

New research may help explain why an anti-cancer drug causes potentially fatal brain inflammation in certain patients. Scientists at Harvard Medical School mimicked the drug's activity in mice and found that it damaged the ...

Recommended for you

Supermaterial gives rejected drugs a new chance

Jul 22, 2014

More than 80 percent of all drug candidates in the pharma R&D suffer from poor solubility and are therefore rejected early in the drug discovery process. Now Uppsala University researchers show that the new ...

Risk of antibiotic overuse in aged care settings

Jul 21, 2014

Antibiotics are being overused in residential aged care facilities (RACFs), and more integrated efforts to improve antibiotic prescribing practices need to be introduced, researchers say. 

Ruconest approved for rare genetic disease

Jul 17, 2014

(HealthDay)—Ruconest has been approved by the U.S. Food and Drug Administration to treat hereditary angioedema, a genetic disease that leads to sudden and potentially fatal swelling of the hands, feet, limbs, face, intestinal ...

NIH system to monitor emerging drug trends

Jul 17, 2014

An innovative National Drug Early Warning System (NDEWS) is being developed to monitor emerging trends that will help health experts respond quickly to potential outbreaks of illicit drugs such as heroin and to identify increased ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

neiorah
not rated yet Aug 12, 2010
This is just lovely bc my daughter has been on this drug for the past year. It has been a bad year for her physically and now i think I know why.